AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-86
Results: 1-25/86
HUMAN APOLIPOPROTEINS A-I AND A-II IN CELL CHOLESTEROL EFFLUX - STUDIES WITH TRANSGENIC MICE
Authors: CHIESA G PAROLINI C CANAVESI M COLOMBO N SIRTORI CR FUMAGALLI R FRANCESCHINI G BERNINI F
Citation: G. Chiesa et al., HUMAN APOLIPOPROTEINS A-I AND A-II IN CELL CHOLESTEROL EFFLUX - STUDIES WITH TRANSGENIC MICE, Arteriosclerosis, thrombosis, and vascular biology, 18(9), 1998, pp. 1417-1423
EVIDENCE-BASED MEDICINE CRITERIA APPLIED TO HYPOLIPIDEMIC AND ANTIHYPERTENSIVE DRUG TRIALS - IS DRUG EFFICACY ALWAYS THE SAME
Authors: CALABRESI L SIRTORI CR
Citation: L. Calabresi et Cr. Sirtori, EVIDENCE-BASED MEDICINE CRITERIA APPLIED TO HYPOLIPIDEMIC AND ANTIHYPERTENSIVE DRUG TRIALS - IS DRUG EFFICACY ALWAYS THE SAME, Pharmacological research, 37(5), 1998, pp. 339-343
DIRECT EFFECTS OF STATINS ON THE VASCULAR WALL
Authors: CORSINI A PAZZUCCONI F ARNABOLDI L PFISTER P FUMAGALLI R PAOLETTI R SIRTORI CR
Citation: A. Corsini et al., DIRECT EFFECTS OF STATINS ON THE VASCULAR WALL, Journal of cardiovascular pharmacology, 31(5), 1998, pp. 773-778
ONE-YEAR TREATMENT WITH ETHYL-ESTERS OF N-3 FATTY-ACIDS IN PATIENTS WITH HYPERTRIGLYCERIDEMIA AND GLUCOSE-INTOLERANCE REDUCED TRIGLYCERIDEMIA, TOTAL CHOLESTEROL AND INCREASED HDL-C WITHOUT GLYCEMIC ALTERATIONS
Authors: SIRTORI CR CREPALDI G MANZATO E MANCINI M RIVELLESE A PAOLETTI R PAZZUCCONI F PAMPARANA F STRAGLIOTTO E
Citation: Cr. Sirtori et al., ONE-YEAR TREATMENT WITH ETHYL-ESTERS OF N-3 FATTY-ACIDS IN PATIENTS WITH HYPERTRIGLYCERIDEMIA AND GLUCOSE-INTOLERANCE REDUCED TRIGLYCERIDEMIA, TOTAL CHOLESTEROL AND INCREASED HDL-C WITHOUT GLYCEMIC ALTERATIONS, Atherosclerosis, 137(2), 1998, pp. 419-427
ELEVATED TRIGLYCERIDES AND LOW HDL CHOLESTEROL IN TRANSGENIC MICE EXPRESSING HUMAN APOLIPOPROTEIN A-I-MILANO
Authors: CHIESA G STOLTZFUS LJ MICHELAGNOLI S BIELICKI JK SANTI M FORTE TM SIRTORI CR FRANCESCHINI G RUBIN EM
Citation: G. Chiesa et al., ELEVATED TRIGLYCERIDES AND LOW HDL CHOLESTEROL IN TRANSGENIC MICE EXPRESSING HUMAN APOLIPOPROTEIN A-I-MILANO, Atherosclerosis, 136(1), 1998, pp. 139-146
SOYBEAN PROTEIN PRODUCTS AS REGULATORS OF LIVER LOW-DENSITY-LIPOPROTEIN RECEPTORS - I - IDENTIFICATION OF ACTIVE BETA-CONGLYCININ SUBUNITS
Authors: LOVATI MR MANZONI C GIANAZZA E SIRTORI CR
Citation: Mr. Lovati et al., SOYBEAN PROTEIN PRODUCTS AS REGULATORS OF LIVER LOW-DENSITY-LIPOPROTEIN RECEPTORS - I - IDENTIFICATION OF ACTIVE BETA-CONGLYCININ SUBUNITS, Journal of agricultural and food chemistry, 46(7), 1998, pp. 2474-2480
SOYBEAN PROTEIN PRODUCTS AS REGULATORS OF LIVER LOW-DENSITY-LIPOPROTEIN RECEPTORS - II - ALPHA-ALPHA' RICH COMMERCIAL SOY CONCENTRATE AND ALPHA' DEFICIENT MUTANT DIFFERENTLY AFFECT LOW-DENSITY-LIPOPROTEIN RECEPTOR ACTIVATION
Authors: MANZONI C LOVATI MR GIANAZZA E MORITA Y SIRTORI CR
Citation: C. Manzoni et al., SOYBEAN PROTEIN PRODUCTS AS REGULATORS OF LIVER LOW-DENSITY-LIPOPROTEIN RECEPTORS - II - ALPHA-ALPHA' RICH COMMERCIAL SOY CONCENTRATE AND ALPHA' DEFICIENT MUTANT DIFFERENTLY AFFECT LOW-DENSITY-LIPOPROTEIN RECEPTOR ACTIVATION, Journal of agricultural and food chemistry, 46(7), 1998, pp. 2481-2484
SOYBEAN PROTEIN PRODUCTS AS REGULATORS OF LIVER LOW-DENSITY-LIPOPROTEIN RECEPTORS - I - IDENTIFICATION OF ACTIVE BETA-CONGLYCININ SUBUNITS (VOL 46, PG 2474, 1998)
Authors: LOVATI MR MANZONI C GIANAZZA E SIRTORI CR
Citation: Mr. Lovati et al., SOYBEAN PROTEIN PRODUCTS AS REGULATORS OF LIVER LOW-DENSITY-LIPOPROTEIN RECEPTORS - I - IDENTIFICATION OF ACTIVE BETA-CONGLYCININ SUBUNITS (VOL 46, PG 2474, 1998), Journal of agricultural and food chemistry, 46(10), 1998, pp. 4464-4464
EARLY EFFICACY AND SAFELY STUDIES
Authors: SIRTORI CR
Citation: Cr. Sirtori, EARLY EFFICACY AND SAFELY STUDIES, The American journal of cardiology, 81(8A), 1998, pp. 13-15
EVALUATION OF LIPOPROTEINS APOLIPOPROTEINS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF VASCULAR AND NONVASCULAR DISEASE/
Authors: SIRTORI CR
Citation: Cr. Sirtori, EVALUATION OF LIPOPROTEINS APOLIPOPROTEINS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF VASCULAR AND NONVASCULAR DISEASE/, The American journal of cardiology, 81(8A), 1998, pp. 36-39
LIPIDS, LIPOPROTEINS, OBESITY AND THE CARDIOVASCULAR RISK, WHAT IS NEW AND WHAT HAS BEEN LEFT ASIDE
Authors: SIRTORI CR VEGA GL
Citation: Cr. Sirtori et Gl. Vega, LIPIDS, LIPOPROTEINS, OBESITY AND THE CARDIOVASCULAR RISK, WHAT IS NEW AND WHAT HAS BEEN LEFT ASIDE, Current opinion in lipidology, 8(4), 1997, pp. 197-199
CLINICAL-EVALUATION OF PROBUCOL IN HYPERCHOLESTEROLEMIA - INDIVIDUAL LIPOPROTEIN RESPONSES AND INHIBITORY EFFECT ON CAROTID ATHEROSCLEROSISPROGRESSION
Authors: BALDASSARRE D FRANCESCHINI G PERUZZOTTI G BRUSONI B SIRTORI CR
Citation: D. Baldassarre et al., CLINICAL-EVALUATION OF PROBUCOL IN HYPERCHOLESTEROLEMIA - INDIVIDUAL LIPOPROTEIN RESPONSES AND INHIBITORY EFFECT ON CAROTID ATHEROSCLEROSISPROGRESSION, Journal of cardiovascular pharmacology, 30(6), 1997, pp. 784-789
PROBUCOL AND MULTIVITAMINS IN THE PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY
Authors: SIRTORI CR FRANCESCHINI G
Citation: Cr. Sirtori et G. Franceschini, PROBUCOL AND MULTIVITAMINS IN THE PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY, The New England journal of medicine, 337(26), 1997, pp. 1918-1918
HIGH-DENSITY-LIPOPROTEIN PARTICLE-SIZE RESTRICTION IN APOLIPOPROTEIN A-I-MILANO TRANSGENIC MICE
Authors: BIELICKI JK FORTE TM MCCALL MR STOLTZFUS LJ CHIESA G SIRTORI CR FRANCESCHINI G RUBIN EM
Citation: Jk. Bielicki et al., HIGH-DENSITY-LIPOPROTEIN PARTICLE-SIZE RESTRICTION IN APOLIPOPROTEIN A-I-MILANO TRANSGENIC MICE, Journal of lipid research, 38(11), 1997, pp. 2314-2321
CAROTID-ARTERY IMT MEASURED WITH AN ELECTRONIC CALIPER IN PATIENTS ATTENDING A LIPID CLINIC
Authors: BALDASSARRE D AMATO M TREMOLI E SIRTORI CR
Citation: D. Baldassarre et al., CAROTID-ARTERY IMT MEASURED WITH AN ELECTRONIC CALIPER IN PATIENTS ATTENDING A LIPID CLINIC, Atherosclerosis, 135, 1997, pp. 6-6
LIMITED CONFORMATIONAL FLEXIBILITY OF A DISULFIDE-LINKED APOLIPOPROTEIN-A-I DIMER IN RECONSTITUTED HIGH-DENSITY-LIPOPROTEINS
Authors: AIROLDI S CALABRESI L VECCHIO G GALBIATI D FRIGERIO F SIRTORI CR FRANCESCHINI G
Citation: S. Airoldi et al., LIMITED CONFORMATIONAL FLEXIBILITY OF A DISULFIDE-LINKED APOLIPOPROTEIN-A-I DIMER IN RECONSTITUTED HIGH-DENSITY-LIPOPROTEINS, Atherosclerosis, 135, 1997, pp. 6-6
INHIBITION OF TNF-ALPHA INDUCED VCAM-1 EXPRESSION ON HUMAN ENDOTHELIAL-CELLS BY RECONSTITUTED HDL
Authors: CALABRESI L TARAMELLI D FERRANTE P SIRTORI CR FRANCESCHINI G
Citation: L. Calabresi et al., INHIBITION OF TNF-ALPHA INDUCED VCAM-1 EXPRESSION ON HUMAN ENDOTHELIAL-CELLS BY RECONSTITUTED HDL, Atherosclerosis, 135, 1997, pp. 7-7
LIPID-METABOLISM IN MICE EXPRESSING HUMAN APOLIPOPROTEIN A-I-MILANO
Authors: CHIESA G BIELICKI JK PAROLINI C COLOMBO N MILIA M VIGNATI L FRANCESCHINI G FORTE TM RUBIN EM SIRTORI CR
Citation: G. Chiesa et al., LIPID-METABOLISM IN MICE EXPRESSING HUMAN APOLIPOPROTEIN A-I-MILANO, Atherosclerosis, 135, 1997, pp. 9-9
SOY PROTEINS AND LDL-RECEPTORS IN HEPG2 CELLS
Authors: LOVATI MR MANZONI C GIANAZZA E SIRTORI CR
Citation: Mr. Lovati et al., SOY PROTEINS AND LDL-RECEPTORS IN HEPG2 CELLS, Atherosclerosis, 135, 1997, pp. 14-14
TRIGLYCERIDES AS PREDICTOR OF TISSUE-PLASMINOGEN ACTIVATOR AND OF TISSUE-PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 LEVELS IN NON OBESE NORMO AND HYPERTRIGLYCERIDEMIC SUBJECTS
Authors: MUSSONI L BALDASSARRE D MANNUCCI L SIRTORI CR TREMOLI E
Citation: L. Mussoni et al., TRIGLYCERIDES AS PREDICTOR OF TISSUE-PLASMINOGEN ACTIVATOR AND OF TISSUE-PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 LEVELS IN NON OBESE NORMO AND HYPERTRIGLYCERIDEMIC SUBJECTS, Atherosclerosis, 135, 1997, pp. 17-17
SOY PROTEIN-DIET SUPPLEMENTATION REDUCES LDL CHOLESTEROL IN SEVERELY HYPERCHOLESTEROLEMIC PATIENTS
Authors: PAZZUCCONI F DELLAMURA N SIRTORI CR
Citation: F. Pazzucconi et al., SOY PROTEIN-DIET SUPPLEMENTATION REDUCES LDL CHOLESTEROL IN SEVERELY HYPERCHOLESTEROLEMIC PATIENTS, Atherosclerosis, 135, 1997, pp. 18-18
EVALUATION OF THE CLINICAL EFFICACY AND POTENTIAL MECHANISM OF THE CHOLESTEROL-LOWERING EFFECT OF SOY PROTEIN
Authors: SIRTORI CR
Citation: Cr. Sirtori, EVALUATION OF THE CLINICAL EFFICACY AND POTENTIAL MECHANISM OF THE CHOLESTEROL-LOWERING EFFECT OF SOY PROTEIN, Atherosclerosis, 134(1-2), 1997, pp. 14-14
MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN A-I-MILANO TRANSGENIC MICE
Authors: PAROLINI C COLOMBO N MILIA M VIGNATI L FRANCESCHINI G SIRTORI CR CHIESA G
Citation: C. Parolini et al., MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN A-I-MILANO TRANSGENIC MICE, Atherosclerosis, 134(1-2), 1997, pp. 35-35
CAROTID ATHEROSCLEROSIS AND VASCULAR RISK-FACTORS IN PATIENTS ATTENDING AN ITALIAN-LIPID-CLINIC
Authors: AMATO M BALDASSARRE D TREMOLI E SIRTORI CR PAOLETTI E
Citation: M. Amato et al., CAROTID ATHEROSCLEROSIS AND VASCULAR RISK-FACTORS IN PATIENTS ATTENDING AN ITALIAN-LIPID-CLINIC, Atherosclerosis, 134(1-2), 1997, pp. 153-153
PRAVASTATIN REDUCES CAROTID INTIMA-MEDIA THICKNESS PROGRESSION ALSO IN PATIENTS SHOWING AN UNSATISFACTORY RESPONSE IN TERMS OF LDL-C REDUCTION - THE CAIUS STUDY
Authors: BALDASSARRE D SIRTORI CR VEGLIA F GOBBI C GALLUS G
Citation: D. Baldassarre et al., PRAVASTATIN REDUCES CAROTID INTIMA-MEDIA THICKNESS PROGRESSION ALSO IN PATIENTS SHOWING AN UNSATISFACTORY RESPONSE IN TERMS OF LDL-C REDUCTION - THE CAIUS STUDY, Atherosclerosis, 134(1-2), 1997, pp. 296-296
Risultati: 1-25 | 26-50 | 51-75 | 76-86